Stifel Financial’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-21,804
| Closed | -$1.06M | – | 2874 |
|
|
2020
Q2 | $1.06M | Buy |
21,804
+766
| +4% | +$37.1K | ﹤0.01% | 1517 |
|
|
2020
Q1 | $886K | Sell |
21,038
-6,351
| -23% | -$267K | ﹤0.01% | 1515 |
|
|
2019
Q4 | $1.17M | Buy |
27,389
+20,964
| +326% | +$896K | ﹤0.01% | 1707 |
|
|
2019
Q3 | $227K | Buy |
+6,425
| New | +$227K | ﹤0.01% | 2589 |
|
|
2018
Q4 | – | Sell |
-11,656
| Closed | -$244K | – | 2657 |
|
|
2018
Q3 | $244K | Buy |
+11,656
| New | +$244K | ﹤0.01% | 2472 |
|
|
2017
Q4 | – | Sell |
-7,373
| Closed | -$279K | – | 2647 |
|
|
2017
Q3 | $279K | Sell |
7,373
-225
| -3% | -$8.51K | ﹤0.01% | 2189 |
|
|
2017
Q2 | $209K | Sell |
7,598
-1,110
| -13% | -$30.5K | ﹤0.01% | 2321 |
|
|
2017
Q1 | $302K | Buy |
8,708
+260
| +3% | +$9.02K | ﹤0.01% | 2085 |
|
|
2016
Q4 | $242K | Sell |
8,448
-2,150
| -20% | -$61.6K | ﹤0.01% | 2166 |
|
|
2016
Q3 | $334K | Sell |
10,598
-468
| -4% | -$14.7K | ﹤0.01% | 1935 |
|
|
2016
Q2 | $359K | Buy |
+11,066
| New | +$359K | ﹤0.01% | 1945 |
|